News | August 08, 2007

IGRT More Widespread Over Next Five Years

August 9, 2007 - Urologists and radiation oncologists expect the use of Image Guided Radiation Therapy (IGRT) to become much more widespread within the next few years, leading to more focused treatment that will be delivered in fewer sessions, according to a report released by market research group IMV Limited.

Despite the availability of many effective therapies, trade-offs between patient lifestyle factors and potential complications of treatment have led to controversy among urologists and radiation oncologists regarding the optimal mix of treatments for localized prostate cancer.
The report, Trends in the Prostate Cancer Treatment Market: 2007 and Beyond, which included 122 urologists and 115 radiation oncologists throughout the United States, indicated that urologists anticipate the use of laparoscopic radical prostatectomy will grow significantly in the near future, applying nerve-sparing techniques and using robotic assistance to assist in surgery as their first-line treatment of choice for patients with localized disease.
Other findings from the report include:

- over 90 percent of the urologists and all of the radiation oncologists in the survey have ordered or performed EBRT procedures for their patients with prostate cancer during the past twelve months.
- 78 percent of respondents have ordered or performed LDR brachytherapy seed implants for their patients with prostate cancer during the past twelve months.

For more information:

Related Content

News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
News | Image Guided Radiation Therapy (IGRT) | July 13, 2017
Elekta and Sunnybrook Health Sciences Centre have initiated installation of Elekta’s MR-linac, an investigational...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017
The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced...
News | Image Guided Radiation Therapy (IGRT) | May 24, 2017
The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as part of a clinical...
Mevion and medPhoton Bring Advanced Cone Beam CT Imaging to Proton Therapy
News | Proton Therapy | May 04, 2017
Mevion Medical Systems announced a strategic agreement with medPhoton GmbH to integrate ImagingRing, an innovative cone...
ViewRay, MRIdian Linac system, FDA 510k approval, MRI-guided radiation therapy
Technology | Image Guided Radiation Therapy (IGRT) | February 27, 2017
February 27, 2017 — ViewRay Inc. announced that the company received 510(k) clearance from the U.S.
Overlay Init